Alzheimer's disease: progress in prediction

The Lancet Neurology

Volumn 9, Issue 1, 2010, Pages 4-5

  Petersen, Ronald C ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; CARBON 11; CLATHRIN ASSEMBLY PROTEIN; CLUSTERIN; COMPLEMENT COMPONENT C3B RECEPTOR; FLUORODEOXYGLUCOSE F 18; PHOSPHATIDYLINOSITOL BINDING CLATHRIN ASSEMBLY PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; EPISODIC MEMORY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HUMAN; MEMORY DISORDER; NERVE CELL DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK FACTOR;

EID: 72049120104     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70330-8     Document Type: Note

References (10)

1. Petersen R, Knopman D, Boeve B, et al. Mild cognitive impairment: ten years later. Arch Neurol (in press).
2. Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer's disease neuroimaging initiative (ADNI): clinical characterization. Neurology (in press).
3. Jack C.R., Knopman D.S., Jagust W.J., et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9 (2010) 119-128
4. Mormino E.C., Kluth J.T., Madison C.M., et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 132 (2009) 1310-1323
5. Jack Jr. C., Low V., Weigand S., et al. Serial PiB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132 (2009) 1355-1365
6. Shaw L.M., Vanderstichele H., Knapik-Czajka M., et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65 (2009) 403-413
7. Mattsson N., Zetterberg H., Hansson O., et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302 (2009) 385-393
8. Visser P.J., Verhey F., Knol D.L., et al. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 8 (2009) 619-627
9. Harold D., Abraham R., Hollingworth P., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41 (2009) 1088-1093
10. Lambert J.C., Heath S., Even G., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41 (2009) 1094-1099